Chung-Che Chang Selected Research

Gln(8)- LHRH

1/2011

Luteinizing Hormone-Releasing Hormone (LHRH)-I antagonist cetrorelix inhibits myeloma cell growth in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chung-Che Chang Research Topics

Disease

19	Neoplasms (Cancer) 01/2021 - 02/2003
7	Lymphoma (Lymphomas) 04/2012 - 11/2005
6	Multiple Myeloma 04/2019 - 12/2002
5	Leukemia 01/2021 - 03/2008
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2013 - 10/2008
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 10/2002
3	Pathologic Complete Response 01/2017 - 10/2002
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2013 - 10/2008
3	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2009 - 10/2008
3	Neoplasm Metastasis (Metastasis) 09/2006 - 05/2003
3	Melanoma (Melanoma, Malignant) 09/2006 - 05/2003
2	Hematologic Neoplasms (Hematological Malignancy) 04/2019 - 09/2010
2	Infections 01/2013 - 12/2003
2	T-Cell Lymphoma (Lymphoma, T Cell) 09/2011 - 10/2007
2	Primary Myelofibrosis (Myelosclerosis) 01/2009 - 10/2008
2	Polycythemia Vera 01/2009 - 10/2008
2	Fibrosis (Cirrhosis) 01/2009 - 03/2003
2	Essential Thrombocythemia 01/2009 - 10/2008
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2005 - 10/2003
1	Adenocarcinoma of Lung 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Neuroendocrine Carcinoma 01/2021
1	Adenocarcinoma 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Immunoglobulin G4-Related Disease 12/2019
1	Sinus Histiocytosis (Rosai-Dorfman Disease) 12/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 11/2019
1	Mast-Cell Leukemia (Leukemia, Mast Cell) 01/2017
1	Papillary Thyroid Cancer 01/2017
1	Testicular Neoplasms (Testicular Cancer) 09/2014
1	Herpes Simplex 01/2013
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 09/2011
1	Genetic Translocation (Chromosomal Translocation) 09/2011
1	Breast Neoplasms (Breast Cancer) 01/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2010
1	Hepatocellular Carcinoma (Hepatoma) 01/2010
1	Lung Neoplasms (Lung Cancer) 01/2010
1	Polycythemia (Erythrocytosis) 06/2009
1	Cytopenia 10/2008

Drug/Important Bio-Agent (IBA)

6	ParaffinIBA 12/2010 - 05/2003
4	Formaldehyde (Formol)FDA Link 12/2010 - 05/2003
4	Monoclonal AntibodiesIBA 09/2006 - 05/2003
3	S100 Proteins (S 100 Protein)IBA 12/2019 - 05/2003
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2006
3	p38 Mitogen-Activated Protein KinasesIBA 04/2012 - 01/2008
3	Biological ProductsIBA 06/2011 - 10/2002
3	RNA (Ribonucleic Acid)IBA 05/2011 - 06/2005
3	AntibodiesIBA 12/2009 - 04/2006
3	Monophenol Monooxygenase (Tyrosinase)IBA 09/2006 - 05/2003
3	MART-1 AntigenIBA 09/2006 - 05/2003
3	Rituximab (Mabthera)FDA Link 02/2004 - 10/2002
2	B7-H1 AntigenIBA 01/2021 - 04/2019
2	Biomarkers (Surrogate Marker)IBA 06/2017 - 04/2013
2	AntigensIBA 09/2014 - 12/2010
2	Complementary DNA (cDNA)IBA 06/2011 - 04/2004
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2006 - 10/2002
1	Immunoglobulin G (IgG)IBA 12/2019
1	Cyclin D1IBA 11/2019
1	Programmed Cell Death 1 ReceptorIBA 04/2019
1	Immune Checkpoint InhibitorsIBA 06/2017
1	Death Domain ReceptorsIBA 06/2017
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	RNA Splicing FactorsIBA 01/2013
1	PolymersIBA 04/2012
1	LipofectamineIBA 04/2012
1	Hexadimethrine BromideIBA 04/2012
1	bcl-X ProteinIBA 04/2012
1	Proteins (Proteins, Gene)FDA Link 09/2011
1	Phosphotransferases (Kinase)IBA 09/2011
1	CytokinesIBA 09/2011
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2011
1	Interleukin-2 (IL2)IBA 09/2011
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 09/2011
1	Anaplastic Lymphoma KinaseIBA 09/2011
1	ChemokinesIBA 09/2011
1	Green Fluorescent ProteinsIBA 06/2011
1	Protein Isoforms (Isoforms)IBA 05/2011
1	cetrorelix (Cetrotide)FDA Link 01/2011
1	Gln(8)- LHRHIBA 01/2011
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2011
1	OligonucleotidesIBA 09/2010
1	Proteasome InhibitorsIBA 01/2010
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 01/2010
1	Bortezomib (Velcade)FDA Link 01/2010
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2010
1	Nucleotide AptamersIBA 12/2009
1	IronIBA 06/2009
1	Erythropoietin FDA Link 06/2009
1	Reticulin (Reticular Fiber)IBA 01/2009
1	Tryptases (Tryptase)IBA 01/2009
1	beta CateninIBA 10/2008
1	Arsenic Trioxide (Trisenox)FDA Link 01/2008
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2007
1	Viral AntigensIBA 10/2007

Therapy/Procedure

5	Therapeutics 01/2021 - 08/2003
4	Drug Therapy (Chemotherapy) 01/2021 - 10/2002
3	Immunotherapy 06/2017 - 10/2007
2	Transplantation 01/2021 - 01/2005
1	Stem Cell Transplantation 01/2021